SUTTON, PAUL ALLEN,GIRGIS, MICHAEL J.,LIANG, JESSICA,PRASHAD, MAHAVIR,VILLHAUER, EDWIN BERNARD
申请号：
CA2813736
公开号：
CA2813736A1
申请日:
2011.10.05
申请国别(地区):
CA
年份:
2012
代理人:
摘要：
The present invention relates to novel crystalline forms of (4-{4-[5-(6-Trifluoromethyl-pyridin-3-ylamino)-pyridin-2-yl]-phenyl}-cyclohexyl)-acetic acid, sodium and their use in the treatment or prevention of a condition or a disorder associated with DGAT1 activity in animals, particularly humans. It also relates processes for making such novel crystalline forms.
